Timing and Duration of Drug Exposure Affects Outcomes of a Drug-Nutrient Interaction During Ontogeny

Author： Ling Binbing   Aziz Caroline   Wojnarowicz Chris   Olkowski Andrew   Alcorn Jane  

Publisher： MDPI

E-ISSN： 1999-4923|2|4|321-338

ISSN： 1999-4923

Source： Pharmaceutics, Vol.2, Iss.4, 2010-10, pp. : 321-338

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update

By Mohn Emily S.   Kern Hua J.   Saltzman Edward   Mitmesser Susan H.   McKay Diane L.  

Pharmaceutics, Vol. 10, Iss. 1, 2018-03 ,pp. : 36-36

MDPI

Access to resources Recommend Favorite

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro

By Weiss Johanna   Theile Dirk   Dvorak Zdenek   Haefeli Walter Emil  

Pharmaceutics, Vol. 6, Iss. 4, 2014-12 ,pp. : 632-650

MDPI

Access to resources Recommend Favorite

iNR-Drug: Predicting the Interaction of Drugs with Nuclear Receptors in Cellular Networking

By Fan Yue-Nong   Xiao Xuan   Min Jian-Liang   Chou Kuo-Chen  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-03 ,pp. : 4915-4937

MDPI

Access to resources Recommend Favorite

Multi-Step Usage of in Vivo Models During Rational Drug Design and Discovery

By Williams Charles H.   Hong Charles C.  

International Journal of Molecular Sciences, Vol. 12, Iss. 4, 2011-04 ,pp. : 2262-2274

MDPI

Access to resources Recommend Favorite

Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny

By Smith Francine G.   Qi Wei  

Pharmaceuticals, Vol. 4, Iss. 1, 2011-01 ,pp. : 154-168

MDPI

Access to resources Recommend Favorite